$TARS

$70.76 +$0.73 (1.04%) Close

$TARS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$TARS Management Team

Dr. Seshadri Neervannan

Chief Operating Officer

Age 56

Compensation $3.195M USD

Sex Male

Ms. Dianne Whitfield

Chief Human Resources Officer

Age 48

Compensation $3.208M USD

Sex Female

Dr. Bryan Wahl

General Counsel

Secretary

Age 47

Compensation $2.534M USD

Sex Male

Dr. Elizabeth Yeu

Chief Medical Officer

Age 46

Compensation $3.105M USD

Sex Female

Mr. Bobak Azamian

Chairman of the Board

President

Chief Executive Officer

Co-Founder

Age 47

Compensation $7.896M USD

Sex Male

Mr. Aziz Mottiwala

Chief Commercial Officer

Age 47

Compensation $3.139M USD

Sex Male

Mr. Jeffrey Farrow

Chief Financial Officer and Chief Strategy Officer

Age 63

Compensation $3.233M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Seshadri Neervannan Chief Operating Officer	56	$3.195M USD	Male
Ms. Dianne Whitfield Chief Human Resources Officer	48	$3.208M USD	Female
Dr. Bryan Wahl General Counsel Secretary	47	$2.534M USD	Male
Dr. Elizabeth Yeu Chief Medical Officer	46	$3.105M USD	Female
Mr. Bobak Azamian Chairman of the Board President Chief Executive Officer Co-Founder	47	$7.896M USD	Male
Mr. Aziz Mottiwala Chief Commercial Officer	47	$3.139M USD	Male
Mr. Jeffrey Farrow Chief Financial Officer and Chief Strategy Officer	63	$3.233M USD	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

7 of 7

stated in the proxy; 1 not stated

Average tenure

Not stated

from year joined

CEO also chairs the board

Yes

Bobak Azamian

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Wendy Yarno Lead independent director	70	Not stated	Independent	None stated	None stated	Not stated
Andrew Goldberg	43	Not stated	Independent	None stated	None stated	$310,284
Scott Morrison	67	Not stated	Independent	None stated	None stated	$316,728
David E.I. Pyott	72	Not stated	Independent	None stated	None stated	Not stated
Bhaskar Chaudhuri	71	Not stated	Independent	None stated	None stated	Not stated
William J. Link	80	Not stated	Independent	None stated	None stated	Not stated
Bobak Azamian Board chair, CEO	47	Not stated	Not stated	None stated	None stated	Paid as CEO
Katherine Goodrich	56	Not stated	Independent	None stated	None stated	$306,728

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 28, 2026

David E.I. Pyott

prior to his appointment to our Board

$25,000

Consulting agreement under which Mr. Pyott served as an advisor to the Company, with annual cash compensation, an option and RSUs

Open in proxy

Dr. Azamian

CEO and Chair of the Board of the Company; serves on the board of the private eye care company

$3.9 million

2024 and 2025

Company purchased preferred stock in a private eye care company (April 2024 and December 2025 investments; Dr. Link, a Board member, also serves on that company's board)

With an early clinical-stage private eye care company Open in proxy

Comments

Company Executives

$TARS Management Team

Dr. Seshadri Neervannan

Ms. Dianne Whitfield

Dr. Bryan Wahl

Dr. Elizabeth Yeu

Mr. Bobak Azamian

Mr. Aziz Mottiwala

Mr. Jeffrey Farrow

Board of Directors

Related-party transactions